ClinicalTrials.Veeva

Menu

Validity of Pain Threshold Index in Children

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Electroencephalography
Anesthesia, General

Treatments

Device: Wavelet index
Device: Pain threshold index

Study type

Interventional

Funder types

Other

Identifiers

NCT03622242
D-1804-059-936

Details and patient eligibility

About

Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group

Full description

Investigators plan to enroll pediatric patients aged between 3 and 12 years old undergoing surgery under general anesthesia with continuous infusion of 2% propofol and remifentanil.

After dividing them into two groups, investigators monitor pain threshold index and wavelet index in test group and adjust remifentanil infusion to maintain both indices in desirable range, while monitoring only wavelet index and adjust remifentanil infusion to maintain wavelet index and conventional vital signs in desirable range in control group.

Investigators compare consumption of remifentanil, time to extubation after surgery, and post-anesthesia care unit length of stay between both groups.

Enrollment

180 estimated patients

Sex

All

Ages

3 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children between 3 and 12 years old undergoing orthopedic surgery at extremities under general anesthesia

Exclusion criteria

  • History of adverse drug reactions to opioids
  • Underlying neurological disease or taking medication for neurologic purpose
  • Patients who were transferred to intensive care unit after the surgery

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 2 patient groups

Pain threshold index group
Experimental group
Description:
Adjust infusion rate of remifentanil and propofol according to pain threshold index and wavelet index in 'pain threshold index group'.
Treatment:
Device: Pain threshold index
Device: Wavelet index
Control group
Active Comparator group
Description:
As conventional management, adjust infusion rate of remifentanil and propofol according to wavelet index and conventional vital signs
Treatment:
Device: Wavelet index

Trial contacts and locations

1

Loading...

Central trial contact

Sang-Hwan Ji, M.D., M.S.; Young-Eun Jang, M.D., M.S.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems